Research targets treatments for Marfan syndrome, aortic dissections

A blood test that identifies enlarged aortas before they rupture shows promise for patients with Marfan syndrome and others with risk factors for the deadly condition, according to a study led by Dr. Hal Dietz of Johns Hopkins University, who has been studying Marfan for decades. Dietz and his team also discovered that a blood pressure medication, losartan, blocks the protein involved in Marfan and seems to reverse some of its effects and stem abnormal growth of the aorta.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief: